Brief: Results From Guard Therapeutics' Phase 1B Study In Cardiac Surgery Published

Disruptive Pharma AB (publ)

20/02/2023 11:11

Feb 20 (Reuters) - Guard Therapeutics International AB
(publ)  GUARD.ST :
    * RESULTS FROM GUARD THERAPEUTICS' PHASE 1B STUDY IN CARDIAC
SURGERY PUBLISHED IN KIDNEY INTERNATIONAL REPORTS
    * PHASE 1B STUDY MET PRIMARY OBJECTIVE AND FORMED BASIS FOR
ONGOING PHASE 2 CLINICAL TRIAL AKITA

Source text for Eikon:  ID:nMFN136Csg 
Further company coverage:  GUARD.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))